Clinical Value of Plasma Humanin in Acute Kidney Injury - Trial NCT06105229
Access comprehensive clinical trial information for NCT06105229 through Pure Global AI's free database. This phase not specified trial is sponsored by Guangdong Provincial People's Hospital and is currently Recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Guangdong Provincial People's Hospital
Timeline & Enrollment
N/A
Aug 01, 2022
Jun 01, 2024
Primary Outcome
Humanin concentration,Serum creatinine concentration
Summary
The goal of this observational study is to assess the clinical value of humanin in acute
 kidney injury. The main questions it aims to answer are:whether Humanin can be a novel marker
 for predicting AKI Researchers will compare humanin concentration in healthy people to see if
 humanin can be a novel marker for predicting AKI
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06105229
Non-Device Trial